Proteomics

Dataset Information

0

Histone post-translational modification analysis from low-abundance clinical samples


ABSTRACT: We streamlined the protein extraction procedure from low-amount clinical samples and tested and implemented different in-gel digestion strategies, obtaining a protocol that allows the analysis of the most common histone PTMs from laser microdissected tissue areas containing as low as 1000 cells. We then applied this protocol to breast cancer patient tissue sections in two proof-of-concept experiments, identifying differences in histone marks in heterogeneous regions selected by either morphological evaluation or MALDI-imaging profiling. These results demonstrate that analyzing histone PTMs from very small tissue areas and detecting differences from adjacent tumor regions is technically feasible, opening the way for the investigation of epigenetic features in the context of tissue and tumor heterogeneity.

INSTRUMENT(S): Q Exactive Plus, Q Exactive HF

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

TISSUE(S): Breast Epithelium, Acinar Cell, Breast, Pancreas, Breast Cancer Cell

DISEASE(S): Breast Cancer

SUBMITTER: Roberta Noberini  

LAB HEAD: Tiziana Bonaldi

PROVIDER: PXD024799 | Pride | 2021-09-09

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
HF191223_FF_100000.raw Raw
HF191223_FF_1000_3.raw Raw
HF191223_FF_1slice_1.raw Raw
HF191223_FF_1slice_2.raw Raw
HF191223_FF_20000_1.raw Raw
Items per page:
1 - 5 of 52
altmetric image

Publications

Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples.

Noberini Roberta R   Savoia Evelyn Oliva EO   Brandini Stefania S   Greco Francesco F   Marra Francesca F   Bertalot Giovanni G   Pruneri Giancarlo G   McDonnell Liam A LA   Bonaldi Tiziana T  

Clinical epigenetics 20210728 1


<h4>Background</h4>Increasing evidence linking epigenetic mechanisms and different diseases, including cancer, has prompted in the last 15 years the investigation of histone post-translational modifications (PTMs) in clinical samples. Methods allowing the isolation of histones from patient samples followed by the accurate and comprehensive quantification of their PTMs by mass spectrometry (MS) have been developed. However, the applicability of these methods is limited by the requirement for subs  ...[more]

Similar Datasets

2022-11-30 | E-MTAB-11903 | biostudies-arrayexpress
2024-10-22 | PXD055559 | Pride
2024-08-09 | PXD037696 | Pride
2009-06-02 | E-GEOD-15299 | biostudies-arrayexpress
2009-02-26 | E-GEOD-13624 | biostudies-arrayexpress
2023-06-23 | PXD027012 | Pride
2010-05-14 | E-GEOD-17294 | biostudies-arrayexpress
2015-02-12 | E-GEOD-51912 | biostudies-arrayexpress
2015-12-10 | PXD001833 | Pride
2013-12-04 | E-GEOD-39697 | biostudies-arrayexpress